A new CDC study suggests that many urgent care centers in the U.S. still need to be made aware of pre-exposure prophylaxis and how to provide it.
"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.
This will likely become the landmark study about the overall rate of neuropsychiatric side effects with this class of medicines over the next several years.
April 11, 2019: acute syphilis and virologic control; neuropsychological performance after switching off efavirenz; structural LGBTQ stigma and HIV criminalization in U.S. states; lung cancer resection surgery in people with HIV.
More awareness of human papillomavirus is needed for gay/bisexual men and transgender women of color -- and their health care providers, research suggests.
However, a number of leading clinicians argue that the results should not deter care providers from prescribing PrEP for patients who are most at risk for HIV.
More research is needed to understand the connections between HIV, mental health, and the neurocircuitry that controls executive function.
Epidemiologists are using a combination of molecular surveillance and tuberculosis-style contact tracing in hopes of helping local health departments curb HIV transmissions.
The data also reveals an estimated 2.3 million people living with HCV infection in the U.S. between 2013 and 2016, with a high burden in the West and in some Appalachian states.
Switching HIV treatment regimens during the first trimester; drivers of viral breakthrough during pregnancy; HIV’s effect on liver risk after hepatitis C treatment; hepatic steatosis among young people with HIV.